Noe D - Search Results

1

A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.

Carducci MA, Gilbert J, Bowling MK, Noe D, Eisenberger MA, Sinibaldi V, Zabelina Y, Chen TL, Grochow LB, Donehower RC. Carducci MA, et al. Among authors: noe d. Clin Cancer Res. 2001 Oct;7(10):3047-55. Clin Cancer Res. 2001. PMID: 11595694 Clinical Trial.

2

Sequence-dependent hematological toxicity associated with the 3-hour paclitaxel/cyclophosphamide doublet.

Kennedy MJ, Zahurak ML, Donehower RC, Noe D, Grochow LB, Sartorius S, Chen TL, Bowling K, Duerr M, Rowinsky EK. Kennedy MJ, et al. Among authors: noe d. Clin Cancer Res. 1998 Feb;4(2):349-56. Clin Cancer Res. 1998. PMID: 9516922 Clinical Trial.

3

Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.

Hantel A, Donehower RC, Rowinsky EK, Vance E, Clarke BV, McGuire WP, Ettinger DS, Noe DA, Grochow LB. Hantel A, et al. Among authors: noe da. Cancer Res. 1990 Jun 1;50(11):3284-8. Cancer Res. 1990. PMID: 2334921

4

Phase I and pharmacokinetic study of brequinar sodium (NSC 368390).

Noe DA, Rowinsky EK, Shen HS, Clarke BV, Grochow LB, McGuire WB, Hantel A, Adams DB, Abeloff MD, Ettinger DS, et al. Noe DA, et al. Cancer Res. 1990 Aug 1;50(15):4595-9. Cancer Res. 1990. PMID: 2369734

5

A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics.

Grochow LB, Noe DA, Ettinger DS, Donehower RC. Grochow LB, et al. Among authors: noe da. Cancer Chemother Pharmacol. 1989;24(5):314-20. doi: 10.1007/BF00304765. Cancer Chemother Pharmacol. 1989. PMID: 2758561

6

Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics.

Grochow LB, Noe DA, Dole GB, Rowinsky EK, Ettinger DS, Graham ML, McGuire WP, Donehower RC. Grochow LB, et al. Among authors: noe da. J Natl Cancer Inst. 1989 Jan 18;81(2):124-30. doi: 10.1093/jnci/81.2.124. J Natl Cancer Inst. 1989. PMID: 2909752

7

Clinical pharmacology of oral and i.v. N-methylformamide: a pharmacologic basis for lack of clinical antineoplastic activity.

Rowinsky EK, Noe DA, Orr DW, Grochow LB, Ettinger DS, Donehower RC. Rowinsky EK, et al. Among authors: noe da. J Natl Cancer Inst. 1988 Jul 6;80(9):671-8. doi: 10.1093/jnci/80.9.671. J Natl Cancer Inst. 1988. PMID: 3373556

8

Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological study.

Rowinsky EK, Ettinger DS, McGuire WP, Noe DA, Grochow LB, Donehower RC. Rowinsky EK, et al. Among authors: noe da. Cancer Res. 1987 Nov 1;47(21):5788-95. Cancer Res. 1987. PMID: 3664482

9

Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.

Rowinsky EK, Noe DA, Grochow LB, Sartorious SE, Bowling MK, Chen TL, Lubejko BG, Kaufmann SH, Donehower RC. Rowinsky EK, et al. Among authors: noe da. J Clin Oncol. 1995 Aug;13(8):1975-84. doi: 10.1200/JCO.1995.13.8.1975. J Clin Oncol. 1995. PMID: 7636538 Clinical Trial.

10

Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.

Chen TL, Passos-Coelho JL, Noe DA, Kennedy MJ, Black KC, Colvin OM, Grochow LB. Chen TL, et al. Among authors: noe da. Cancer Res. 1995 Feb 15;55(4):810-6. Cancer Res. 1995. PMID: 7850794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters